首页> 外文期刊>BMC Bioinformatics >PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison
【24h】

PGxO and PGxLOD: a reconciliation of pharmacogenomic knowledge of various provenances, enabling further comparison

机译:PGXO和PGXLOD:调和各种杂种的药物知识,从而进一步比较

获取原文
           

摘要

Pharmacogenomics (PGx) studies how genomic variations impact variations in drug response phenotypes. Knowledge in pharmacogenomics is typically composed of units that have the form of ternary relationships gene variant - drug - adverse event. Such a relationship states that an adverse event may occur for patients having the specified gene variant and being exposed to the specified drug. State-of-the-art knowledge in PGx is mainly available in reference databases such as PharmGKB and reported in scientific biomedical literature. But, PGx knowledge can also be discovered from clinical data, such as Electronic Health Records (EHRs), and in this case, may either correspond to new knowledge or confirm state-of-the-art knowledge that lacks "clinical counterpart" or validation. For this reason, there is a need for automatic comparison of knowledge units from distinct sources. In this article, we propose an approach, based on Semantic Web technologies, to represent and compare PGx knowledge units. To this end, we developed PGxO, a simple ontology that represents PGx knowledge units and their components. Combined with PROV-O, an ontology developed by the W3C to represent provenance information, PGxO enables encoding and associating provenance information to PGx relationships. Additionally, we introduce a set of rules to reconcile PGx knowledge, i.e. to identify when two relationships, potentially expressed using different vocabularies and levels of granularity, refer to the same, or to different knowledge units. We evaluated our ontology and rules by populating PGxO with knowledge units extracted from PharmGKB (2701), the literature (65,720) and from discoveries reported in EHR analysis studies (only 10, manually extracted); and by testing their similarity. We called PGxLOD (PGx Linked Open Data) the resulting knowledge base that represents and reconciles knowledge units of those various origins. The proposed ontology and reconciliation rules constitute a first step toward a more complete framework for knowledge comparison in PGx. In this direction, the experimental instantiation of PGxO, named PGxLOD, illustrates the ability and difficulties of reconciling various existing knowledge sources.
机译:药物替昔代理学(PGX)研究基因组变异如何影响药物反应表型的变化。药物替补症的知识通常由具有三元关系基因变异 - 药物 - 不良事件形式的单位组成。这种关系指出,对于具有特定基因变体并暴露于特定药物的患者,可能会发生不良事件。 PGX中的最先进的知识主要是参考数据库,如PharmgKB,并在科学生物医学文献中报道。但是,也可以从临床数据中发现PGX知识,例如电子健康记录(EHRS),并且在这种情况下,可以对应于新的知识或确认缺乏“临床对应物”或验证的最先进的知识。因此,需要自动比较知识单元来自不同的来源。在本文中,我们提出了一种基于语义网络技术的方法来表示和比较PGX知识单元。为此,我们开发了PGXO,这是一种代表PGX知识单元及其组件的简单本体。结合PROP-O,由W3C开发的本体学代表出处信息,PGXO使得能够对PGX关系进行编码和关联出处理。此外,我们介绍了一组规则来协调PGX知识,即识别何时使用不同词汇表和粒度水平的两个关系,参见相同的或不同的知识单元。我们通过从PharmgKB(2701)中提取的知识单元,文献(65,720)和EHR分析研究中报告的发现(仅为10,手动提取),通过从PharmgKB(2701)中提取的知识单元进行了评估了我们的本体和规则并通过测试它们的相似性。我们称为PGXLOD(PGX链接开放数据)所产生的知识库,表示和调和各种起源的知识单位。拟议的本体和解规则构成了迈向PGX中的更完整框架的第一步。在这个方向上,PGXO的实验实例命名为PGXLOD,说明了协调各种现有知识来源的能力和困难。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号